Is the efflux pump inhibitor Verapamil a potential booster for isoniazid against Mycobacterium tuberculosis?. (2020). Brazilian Journal of Pharmaceutical Sciences, 56, e18309 . https://doi.org/10.1590/s2175-97902020000218309